INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $292 | +19.2% | 15,728 | -29.0% | 0.02% | +15.8% |
Q2 2023 | $245 | +23.1% | 22,167 | +49.9% | 0.02% | +26.7% |
Q1 2023 | $199 | +15.7% | 14,790 | +6.2% | 0.02% | +7.1% |
Q4 2022 | $172 | -99.9% | 13,932 | -10.2% | 0.01% | -30.0% |
Q3 2022 | $216,000 | -10.7% | 15,508 | -11.7% | 0.02% | -9.1% |
Q2 2022 | $242,000 | +30.1% | 17,559 | +53.6% | 0.02% | +266.7% |
Q1 2022 | $186,000 | – | 11,431 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |